{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:40:36Z","timestamp":1790487636432,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NSHI"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.rmed.2014.12.006","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T19:45:27Z","timestamp":1419882327000},"page":"228-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population"],"prefix":"10.1016","volume":"109","author":[{"given":"Lorcan","family":"McGarvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Gruffydd-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddie","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Haughney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2014.12.006_bib1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1183\/09031936.06.00145104","article-title":"Outcomes and markers in the assessment of chronic obstructive pulmonary disease","volume":"27","author":"Jones","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.12.006_bib2","unstructured":"The global initiative for chronic obstructive Lung disease (GOLD), revised 2014. www.goldcopd.com. [Last accessed 27.0214]."},{"key":"10.1016\/j.rmed.2014.12.006_bib3","unstructured":"National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in Adults in primary and secondary care, Updated 2010. http:\/\/publications.nice.org.uk\/chronic-obstructive-pulmonary-disease-cg101. [Last accessed 03.1013]."},{"key":"10.1016\/j.rmed.2014.12.006_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1741-7015-11-181","article-title":"Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease","volume":"11","author":"Wedzicha","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.rmed.2014.12.006_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/thx.2003.008730","article-title":"Exacerbations impair quality of life in patients with chronic obstructive pulmonary disease. A two-year follow-up study","volume":"59","author":"Miravitlles","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.12.006_bib6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1164\/rccm.201110-1843OC","article-title":"Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations","volume":"185","author":"Mackay","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2014.12.006_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/thorax.58.2.100","article-title":"Risk factors of readmission to hospital for a COPD exacerbation: a prospective study","volume":"58","author":"Garcia-Aymerich","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.12.006_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.06-1316","article-title":"Risk indexes for exacerbations and hospitalizations due to COPD","volume":"131","author":"Niewoehner","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2014.12.006_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Cataluna","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.12.006_bib10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1378\/chest.128.4.1995","article-title":"Airway and systemic inflammation and decline in lung function in patients with COPD","volume":"128","author":"Donaldson","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2014.12.006_bib11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","article-title":"Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality","volume":"67","author":"Suissa","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.12.006_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2014.12.006_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/COPD.S34186","article-title":"Exacerbation frequency and course of COPD","volume":"7","author":"Halpin","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.rmed.2014.12.006_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1465-9921-14-116","article-title":"Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial","volume":"14","author":"Beeh","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.rmed.2014.12.006_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1185\/03007995.2013.867842","article-title":"Chronic obstructive pulmonary disease and exacerbations: clinician insights from the global hidden depths of COPD survey","volume":"30","author":"Barnes","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rmed.2014.12.006_bib16","article-title":"The distribution of COPD in UK general practice using the new GOLD classification","author":"Haughney","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.12.006_bib17","unstructured":"NHS connecting for health read codes. http:\/\/www.connectingforhealth.nhs.uk\/systemsandservices\/data\/uktc\/readcodes. [Last accessed 09.1013]."},{"key":"10.1016\/j.rmed.2014.12.006_bib18","first-page":"300","article-title":"COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care","volume":"11","author":"Thomas","year":"2014","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2014.12.006_bib19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.201311-2006PP","article-title":"Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team","volume":"189","author":"Vestbo","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2014.12.006_bib20","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.12.006_bib21","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1378\/chest.128.4.2099","article-title":"Patterns of comorbidities in newly diagnosed COPD and asthma in primary care","volume":"128","author":"Soriano","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2014.12.006_bib22","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.rmed.2011.04.005","article-title":"Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease","volume":"105","author":"Dalal","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2014.12.006_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1378\/chest.11-0853","article-title":"The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD","volume":"141","author":"Patel","year":"2012","journal-title":"Chest"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114004442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114004442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:32:22Z","timestamp":1760614342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611114004442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0954611114004442"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2014.12.006","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2014.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}